Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myeloperoxidase (MPO), quinone oxidoreductase (NQO1), and glutathione S-transferases (GSTs)

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 516, Issue 1-2, 2002, Pages 41-47

  Brockstedt, Ulrike ^a   Krajinovic, Maja ^a   Richer, Chantal ^a   Mathonnet, Geraldine ^a   Sinnett, Daniel ^a   Pfau, Wolfgang ^b   Labuda, Damian ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b University of Medical School Hamburg Eppendorf   (Germany)

Author keywords

Breast tissue; Chemical carcinogenesis; DNA adducts; Genetic polymorphisms

Indexed keywords

CARCINOGEN; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; ENZYME; GLUTATHIONE TRANSFERASE; MYELOPEROXIDASE; OXIDOREDUCTASE; PHOSPHORUS 32; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; XENOBIOTIC AGENT;

ADULT; ALLELE; ARTICLE; BREAST CARCINOGENESIS; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; WILD TYPE;

ADOLESCENT; ADULT; BREAST; BREAST NEOPLASMS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; DNA ADDUCTS; DNA, NEOPLASM; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); PEROXIDASE; POLYMORPHISM, GENETIC;

EID: 0037177543     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(02)00019-0     Document Type: Article

References (35)

1. Mechanisms of carcinogenesis and individual susceptibility to cancer
2. Genetic epidemiology of environmental toxicity and cancer susceptibility: Human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues
3. Metabolism of xenobiotics and chemical carcinogenesis
4. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers
5. Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1, CYP2D6 and GSTM1 genetic polymorphisms
6. Lymphocytes, DNA adducts and genetic polymorphism for metabolic enzymes in low dose cigarette smokers
7. Contribution of genetic and nutritional factors to DNA damage in heavy smokers
8. Association between polycyclic aromatic hydrocarbon-DNA adduct levels in maternal and newborn white blood cells and glutathione S-transferase P1 and CYP1A1 polymorphisms
9. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism
10. NAD(P)H: Quinone oxidoreductase 1 (NQO1): Chemoprotection, bioactivation, gene regulation and genetic polymorphisms
11. Role of NAD(P)H: Quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity
12. Analyses of bronchial bulky DNA adduct levels and CYP2C9, GSTP1 and NQO1 genotypes in a Hungarian study population with pulmonary diseases
13. Activation of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to diolepoxides by human polymorphonuclear leukocytes or myeloperoxidase
14. Polymorphisms for aromatic amine metabolism in humans: Relevance for human carcinogenesis
15. Pathways of heterocyclic amine activation in the breast: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) formed by peroxidases and in human mammary epithelial cells and fibroblasts
16. Diet, metabolic polymorphisms and DNA adducts: The EPIC-Italy cross-sectional study
17. Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear white blood cells
18. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk
19. Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure
20. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo
21. The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue
22. The effect of the genetic polymorphisms of CYP1A1, CYP2D6, GSTM1 and GSTP1 on aromatic DNA adduct levels in the population of healthy women
23. DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer
24. DNA adducts in human breast tissue: Association with N-acetyltransferase-2 (NAT2) and NAT1 genotypes
25. Rapid detection of CYP1A1, CYP2D6, and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay
26. Genetic susceptibility to breast cancer in French-Canadians: Role of carcinogen-metabolizing enzymes and gene-environment interactions
27. Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia
28. Susceptibility to childhood acute lymphoblastic leukemia: Influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms
29. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element
30. Myeloperoxidase-463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patients
31. 32P-labeled nucleotide adducts formed by food-derived carcinogenic aminoimidazoazarenes
32. 32P-post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: Evidence for incomplete hydrolysis and a procedure for adduct pattern simplification
33. 32P-labelled nucleoside 3′-, 5′-bisphosphate adducts of polycyclic aromatic hydrocarbons
34. Sulphoxidation reaction catalysed by myeloperoxidase from human leucocytes
35. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: Correlation with lung DNA adduct levels